ATE555194T1 - Methode zur herstellung von proliferierenden und differenzierenden zelllinien - Google Patents

Methode zur herstellung von proliferierenden und differenzierenden zelllinien

Info

Publication number
ATE555194T1
ATE555194T1 AT02788154T AT02788154T ATE555194T1 AT E555194 T1 ATE555194 T1 AT E555194T1 AT 02788154 T AT02788154 T AT 02788154T AT 02788154 T AT02788154 T AT 02788154T AT E555194 T1 ATE555194 T1 AT E555194T1
Authority
AT
Austria
Prior art keywords
cell lines
differentiating cell
proliferating
producing
producing proliferating
Prior art date
Application number
AT02788154T
Other languages
English (en)
Inventor
Hergen Spits
M Naspetti
Ferenc Scheeren
Bianca Blom
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0130223A external-priority patent/GB0130223D0/en
Priority claimed from GB0206086A external-priority patent/GB0206086D0/en
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of ATE555194T1 publication Critical patent/ATE555194T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/52—CD40, CD40-ligand (CD154)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Ceramic Products (AREA)
AT02788154T 2001-12-18 2002-12-18 Methode zur herstellung von proliferierenden und differenzierenden zelllinien ATE555194T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0130223A GB0130223D0 (en) 2001-12-18 2001-12-18 Materials and methods relating to the production and maintenance of cell lines
GB0206086A GB0206086D0 (en) 2002-03-14 2002-03-14 Materials and methods relating to the production and maintenance of cell lines
PCT/GB2002/005753 WO2003052083A2 (en) 2001-12-18 2002-12-18 Methods for the generation of proliferating and differentiating cell lines

Publications (1)

Publication Number Publication Date
ATE555194T1 true ATE555194T1 (de) 2012-05-15

Family

ID=26246880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02788154T ATE555194T1 (de) 2001-12-18 2002-12-18 Methode zur herstellung von proliferierenden und differenzierenden zelllinien

Country Status (10)

Country Link
US (2) US8318487B2 (de)
EP (2) EP1458855B1 (de)
JP (3) JP4818585B2 (de)
AT (1) ATE555194T1 (de)
AU (1) AU2002352436B2 (de)
DK (1) DK1458855T3 (de)
ES (1) ES2384960T3 (de)
NZ (1) NZ534107A (de)
SI (1) SI1458855T1 (de)
WO (1) WO2003052083A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006505266A (ja) * 2002-11-08 2006-02-16 株式会社リプロセル 幹細胞の増幅因子
WO2005052139A2 (en) * 2003-11-19 2005-06-09 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Method of inducing memory b cell development and terminal differentiation
JP2008509663A (ja) * 2004-08-10 2008-04-03 アカデミシュ メディシュ セントラム ビ デ ユニベルシテイト ファン アムステルダム 関心のある安定化された細胞を生産するための手段及び方法
EP1627563A1 (de) * 2004-08-10 2006-02-22 Academisch Medisch Centrum bij de Universiteit van Amsterdam Verfahren und Mittel zur Herstellung einer stabilisierten Zelle
ATE512228T1 (de) 2005-11-17 2011-06-15 Tet Systems Gmbh & Co Kg Induzierbare expressionssysteme
USRE49583E1 (en) 2005-11-17 2023-07-18 Tet Systems Gmbh & Co. Kg Inducible expression systems
NZ592159A (en) 2005-12-09 2012-12-21 Amc Amsterdam Means and methods for influencing the stability of antibody producing cells
US9005974B2 (en) * 2005-12-09 2015-04-14 Academish Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
EP1997830A1 (de) * 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US20110236393A1 (en) * 2008-11-04 2011-09-29 Duke University Monoclonal antibody production in b cells and uses therof
US9273118B2 (en) 2009-07-15 2016-03-01 Aimm Therapeutics B.V. Means and methods for producing high affinity antibodies
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
CN103429615B (zh) 2010-12-02 2018-03-16 埃姆医疗有限公司 用于生产高亲和力抗体的方式和方法
CA2938193C (en) 2014-01-31 2023-05-02 Aimm Therapeutics B.V. Means and methods for producing stable antibodies
JP6684211B2 (ja) 2014-07-02 2020-04-22 学校法人東京理科大学 Ｂ細胞集団の製造方法
WO2021231569A1 (en) * 2020-05-14 2021-11-18 Seattle Children's Hospital (dba Seattle Children's Research Institute) Dual promoter systems
US20250074959A1 (en) * 2021-05-14 2025-03-06 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Activity-inducible fusion proteins having a transcription factor and a heat shock protein 90 binding domain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233408T2 (de) 1991-12-02 2005-09-22 Cambridge Antibody Technology Ltd., Melbourn Herstellung von Antikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken.
ATE309267T1 (de) 1994-04-28 2005-11-15 Boehringer Ingelheim Pharma Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
DE19541844C1 (de) 1995-11-09 1997-07-24 Gsf Forschungszentrum Umwelt Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung
EP1146869A2 (de) * 1999-01-27 2001-10-24 University Of South Florida Inhibierung der stat3 signaltransduktion für krebsbehandlung
US6159694A (en) * 1999-04-08 2000-12-12 Isis Pharmaceuticals Inc. Antisense modulation of stat3 expression
US20020090692A1 (en) * 1999-09-30 2002-07-11 Prayaga Sudhirdas K. Novel polynucleotides and polypeptides encoded thereby
EP1397382B1 (de) * 2001-05-31 2008-08-06 Novartis AG Neue östrogenrezeptorligandenbindungsdomänen varianten und neue liganden und pharmazeutische zusammensetzungen
PL371773A1 (en) * 2001-07-23 2005-06-27 Immunex Corporation Modified human thymic stromal lymphopoietin

Also Published As

Publication number Publication date
ES2384960T3 (es) 2012-07-16
JP2009142292A (ja) 2009-07-02
JP2012235795A (ja) 2012-12-06
NZ534107A (en) 2007-02-23
AU2002352436A1 (en) 2003-06-30
US20090275139A1 (en) 2009-11-05
DK1458855T3 (da) 2012-07-23
EP1458855A2 (de) 2004-09-22
JP4818585B2 (ja) 2011-11-16
JP2005512540A (ja) 2005-05-12
AU2002352436B2 (en) 2008-05-22
EP1458855B1 (de) 2012-04-25
EP2141228A1 (de) 2010-01-06
US8318487B2 (en) 2012-11-27
US8389281B2 (en) 2013-03-05
WO2003052083A3 (en) 2003-11-27
WO2003052083A2 (en) 2003-06-26
SI1458855T1 (sl) 2012-08-31
US20060153820A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
ATE555194T1 (de) Methode zur herstellung von proliferierenden und differenzierenden zelllinien
ATE421994T1 (de) Genexpressionsmethode
TWI315740B (de)
WO2003012058A3 (en) Media and methods for cultivation of microorganisms
ATE309331T1 (de) Transplant-akzeptanz induzierende zellen monocytären ursprungs, sowie deren herstellung und verwendung
AU2003224475A1 (en) High-density read-only optical disc, and optical disc apparatus and method using the same background of the invention
ATE520466T1 (de) Apparat und verfahren zur modifizierung von magnetisch inmmobilizierte biomolekulen
DE60203761D1 (de) Methode zur Herstellung von Synthesegas und Methode zur Herstellung von Methanol
DE60330841D1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
DE60235836D1 (de) Ahren und verwendung davon
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
ATE522035T1 (de) Verfahren und system zur verarbeitung von optischen signalen
EP1668125A4 (de) Modifizierte enzyme, verfahren zur herstellung modifizierter enzyme und verwendungen davon
IS7154A (is) Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun
DE59900867D1 (de) Elektrolyseapparat zur herstellung von halogengasen
PL367306A1 (pl) Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE384117T1 (de) Verwendung einer miniaturvorrichtung zur trennung und isolierung biologischer objekte und trennungsverfahren
ATE323173T1 (de) Nährboden zum nachweis und/oder zur unterscheidung von enterokokken
ATE389014T1 (de) Phosphorylierte glyoxalase i und deren verwendung
DK0674007T3 (da) Fremgangsmåde til fremstilling af pilocarpin
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
AU6383700A (en) Mammalian cytokines; related reagents
CY1116753T1 (el) Μεθοδοι για την παραγωγη παρασκευασματων υψηλου τιτλου χωρις βοηθους των αποδεσμευμενων ανασυνδυασμενων φορεων aav
ATE140730T1 (de) Dns-segmente und das delta-1 des hydrogenasegen enthaltende mikroorganismen und ihre verwendung